News

Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests
After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk ...
Long Island patients lost vision after taking weight loss drugs Ozempic and Wegovy, lawyer contends
The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...
Popular injected weight loss medications work better for one sex. Researchers want to know why
In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.
Weight-loss drugs’ impact on cancer risk revealed in new study
Weight-loss drugs and bariatric surgery both have an impact on cancer risk. A new study breaks down the link and how GLP-1 ...
New daily ‘gastric bypass pill’ leads to consistent weight loss — and no side effects: study
The millions of people living with obesity need novel treatment options that are safe, effective and avoid the high costs and ...
Weight-loss company Noom pivots to smaller doses of compounded Wegovy
Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.
Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs
The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market ...